Targeting chemokine (C-C motif) ligand 2 (CCL2) as an example of translation of cancer molecular biology to the clinic.
about
Cytokine patterns in cancer patients: A review of the correlation between interleukin 6 and prognosisMulti-scale in vivo systems analysis reveals the influence of immune cells on TNF-α-induced apoptosis in the intestinal epitheliumOverexpression of lipocalins and pro-inflammatory chemokines and altered methylation of PTGS2 and APC2 in oral squamous cell carcinomas induced in rats by 4-nitroquinoline-1-oxidePlatelet adhesion and degranulation induce pro-survival and pro-angiogenic signalling in ovarian cancer cells.Diallyl disulfide inhibits TNFα-induced CCL2 release by MDA-MB-231 cells.Metformin limits the adipocyte tumor-promoting effect on ovarian cancer.Changed adipocytokine concentrations in colorectal tumor patients and morbidly obese patients compared to healthy controls.Systemic DNA damage related to cancerIdentification of Reprogrammed Myeloid Cell Transcriptomes in NSCLCTumor-cell co-culture induced alternative activation of macrophages is modulated by interferons in vitro.Inhalation of sulfur mustard causes long-term T cell-dependent inflammation: possible role of Th17 cells in chronic lung pathology.Diallyl disulfide inhibits TNFα induced CCL2 release through MAPK/ERK and NF-Kappa-B signaling.Antitumor Activity of a Novel Sphingosine-1-Phosphate 2 Antagonist, AB1, in Neuroblastoma.How do cytokines trigger genomic instability?LKB1 loss promotes endometrial cancer progression via CCL2-dependent macrophage recruitmentOvercoming melanoma resistance to vemurafenib by targeting CCL2-induced miR-34a, miR-100 and miR-125bImmunosuppressive parameters in serum of ovarian cancer patients change during the disease course.Inhibition of CCL2 signaling in combination with docetaxel treatment has profound inhibitory effects on prostate cancer growth in bone.Mesenchymal stem cell-derived CCL-9 and CCL-5 promote mammary tumor cell invasion and the activation of matrix metalloproteinases.Targeting the androgen receptor with siRNA promotes prostate cancer metastasis through enhanced macrophage recruitment via CCL2/CCR2-induced STAT3 activation.Brain metastasis in renal cancer patients: metastatic pattern, tumour-associated macrophages and chemokine/chemoreceptor expression.Macrophages in cancer and infectious diseases: the 'good' and the 'bad'.Inflammation and prostate cancer: friends or foe?Targeting of tumour-infiltrating macrophages via CCL2/CCR2 signalling as a therapeutic strategy against hepatocellular carcinoma.Circulating T regulatory cells migration and phenotype in glioblastoma patients: an in vitro study.PPM1A is a RelA phosphatase with tumor suppressor-like activity.Highly specific targeting of the TMPRSS2/ERG fusion gene using liposomal nanovectors.Cytokine-like 1 Chemoattracts Monocytes/Macrophages via CCR2.Induction of chemokine (C-C motif) ligand 2 by sphingosine-1-phosphate signaling in neuroblastoma.Progress and prospects of early detection in lung cancer.Pathways of metastasizing intestinal cancer cells revealed: how will fighting metastases at the site of cancer cell arrest affect drug development?Mutant CCL2 protein coating mitigates wear particle-induced bone loss in a murine continuous polyethylene infusion model.Multifaceted Roles for Macrophages in Prostate Cancer Skeletal Metastasis.Cancer Cells Exploit Notch Signaling to Redefine a Supportive Cytokine Milieu
P2860
Q26741263-AD82D306-1CC0-44DB-92D6-49DB8AAA2DA5Q27318698-81FCF189-3231-4A1E-A125-92FC210A9FC3Q28543174-7502F0FD-67BC-4D71-BE4A-AF69F7DF5C89Q34056033-62EB42EA-80E1-44D9-9FBE-3A232F35ADEDQ34056943-04B1C9E2-3D20-4F51-B73E-6AD4E0F21E65Q34104019-67D4DB91-D778-4891-B823-0E7F72387325Q34485557-5769A4A4-85F3-425D-9AC6-304FE38F39F3Q34988152-77A87386-9883-4CA3-BD4E-D86FBE57B45FQ35654027-7FE8FA70-531B-4861-BE17-6E03720908C0Q35872012-010DC1C5-5E4F-4829-B422-4773B25EA15FQ35923173-9C65BBB0-AAED-43AE-A7C0-94533B2AA39FQ35940908-E595B6F9-65C9-4EE0-BCA7-D6C7F0B8FE80Q35962030-9F7914A4-F8D1-4641-BADA-0238F1F507D4Q36057809-BACAB471-2D82-4239-916D-F19F8612E760Q36266500-489F5471-B18B-46BC-8E50-868F8ACF5E67Q36782461-07C820E4-54A4-4B0E-8FEC-F9595A8D0025Q36821077-B59F2EF8-AA79-480B-966E-47CA415A7A2AQ36913771-734AE29A-15D3-4164-8CB4-310C2788D849Q37014822-0E038271-9229-46D8-A994-9CFB96BC686AQ37236912-5AD9BCF2-A147-4718-A6AA-F544356CAED7Q37559001-A714D7BD-E903-4B39-A4C8-C66D0E28DB64Q37945300-B1E81664-5C4B-44D7-8626-796F1096B2C8Q38383521-110389A0-90F6-456D-8B4D-9BB397255634Q38829170-17D2C33C-6025-4379-86AD-E25A18D08D1CQ39100186-B609AEE0-74B8-4D64-8763-C830DE81DA86Q39132976-4CF2EE92-A508-4E29-BC52-3BBE38B5D68CQ39262686-10995C54-BE69-450A-A1E6-BAF97C551E8AQ39847007-1BA84CD5-CBB5-4C93-BFF4-1CBE44DE316AQ41980679-3F1C92F7-F5B7-4C85-8809-8F29E2FFD186Q42139806-4D70AE79-E356-4F79-B24A-353644F6F194Q43886020-612643B3-C9B4-4BD6-8D47-B9EA6BEB141EQ48912595-0DA756CD-C8F4-4E9E-8A3D-5492874650D1Q55364968-ABF4834D-8407-450E-A6EF-70C2404C0A40Q58781616-27C30628-5292-48FA-82F9-56954FA1A323
P2860
Targeting chemokine (C-C motif) ligand 2 (CCL2) as an example of translation of cancer molecular biology to the clinic.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Targeting chemokine (C-C motif ...... lecular biology to the clinic.
@en
Targeting chemokine
@nl
type
label
Targeting chemokine (C-C motif ...... lecular biology to the clinic.
@en
Targeting chemokine
@nl
prefLabel
Targeting chemokine (C-C motif ...... lecular biology to the clinic.
@en
Targeting chemokine
@nl
P2860
P1476
Targeting chemokine (C-C motif ...... lecular biology to the clinic.
@en
P2093
Jian Zhang
P2860
P356
10.1016/B978-0-12-385071-3.00003-4
P577
2010-01-01T00:00:00Z